Literature DB >> 32314897

[Overview of animal researches about the effects of systemic drugs on implant osseointegration].

Ya-Nan Wang1, Ting-Ting Jia1, Xin Xu2, Dong-Jiao Zhang2.   

Abstract

Implant osseointegration is an important biological basis for dental implantology. Many factors, including surgical factors, implant factors, and patients' own factors, affect implant osseointegration. Notably, the application of systemic drugs to improve implant osseointegration has become a research hotspot. This article reviews the effects of systemic drugs on implant osseointegration based on animal researches to provide systemic drug selection to improve implant osseointegration and lay a good foundation for later clinical trials.

Entities:  

Keywords:  animal researches; implant; osseointegration; systemic drugs

Mesh：

Substances：

Year:  2020        PMID： 32314897      PMCID： PMC7184276          DOI： 10.7518/hxkq.2020.02.017

Source DB:  PubMed          Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi        ISSN： 1000-1182


  73 in total

1.  The bisphosphonate ibandronate improves implant integration in osteopenic ovariectomized rats.

Authors:  A H A Kurth; C Eberhardt; S Müller; M Steinacker; M Schwarz; F Bauss
Journal:  Bone       Date:  2005-08       Impact factor: 4.398

2.  Effects of Alendronate on Bone Remodeling Around Osseointegrated Implants in Rats.

Authors:  Kyung Chul Oh; Woojin Hwang; Young Bum Park; Jae Hoon Lee; Hong Seok Moon; Jee Hwan Kim
Journal:  Implant Dent       Date:  2017-02       Impact factor: 2.454

3.  Basic Fibroblast Growth Factor Induces Angiogenic Properties of Fibrocytes to Stimulate Vascular Formation during Wound Healing.

Authors:  Miho Nakamichi; Yuri Akishima-Fukasawa; Chie Fujisawa; Tetuo Mikami; Kiyoshi Onishi; Yoshikiyo Akasaka
Journal:  Am J Pathol       Date:  2016-10-20       Impact factor: 4.307

Review 4.  Strontium ranelate for preventing and treating postmenopausal osteoporosis.

Authors:  S O'Donnell; A Cranney; G A Wells; J D Adachi; J Y Reginster
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

5.  Raloxifene but not alendronate can compensate the impaired osseointegration in osteoporotic rats.

Authors:  Leonardo Perez Faverani; Tárik Ocon Braga Polo; Gabriel Ramalho-Ferreira; Gustavo Antonio Correa Momesso; Jaqueline Suemi Hassumi; Ana Cláudia Rossi; Alexandre Rodrigues Freire; Felippe Bevilacqua Prado; Eloá Rodrigues Luvizuto; Reinhard Gruber; Roberta Okamoto
Journal:  Clin Oral Investig       Date:  2017-03-29       Impact factor: 3.573

6.  Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.

Authors:  R M Neer; C D Arnaud; J R Zanchetta; R Prince; G A Gaich; J Y Reginster; A B Hodsman; E F Eriksen; S Ish-Shalom; H K Genant; O Wang; B H Mitlak
Journal:  N Engl J Med       Date:  2001-05-10       Impact factor: 91.245

7.  1,25Dihydroxy vitamin D(3) improves titanium implant osseointegration in osteoporotic rats.

Authors:  Chenchen Zhou; Yunfeng Li; Xuemei Wang; Xueping Shui; Jing Hu
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2012-05-12

8.  The effect of alendronate on biomineralization at the bone/implant interface.

Authors:  Johan Karlsson; Anna Martinelli; Hoda M Fathali; Johan Bielecki; Martin Andersson
Journal:  J Biomed Mater Res A       Date:  2015-11-12       Impact factor: 4.396

9.  Early effects of parathyroid hormone on vascularized bone regeneration and implant osseointegration in aged rats.

Authors:  Liting Jiang; Wenjie Zhang; Li Wei; Qi Zhou; Guangzheng Yang; Niandong Qian; Yun Tang; Yiming Gao; Xinquan Jiang
Journal:  Biomaterials       Date:  2018-06-26       Impact factor: 12.479

10.  FGF-2 promotes initial osseointegration and enhances stability of implants with low primary stability.

Authors:  Toshie Nagayasu-Tanaka; Takenori Nozaki; Koji Miki; Keigo Sawada; Masahiro Kitamura; Shinya Murakami
Journal:  Clin Oral Implants Res       Date:  2016-02-26       Impact factor: 5.977
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.